Search

Author/Creator Mantry, P.

1. Open‐label study of faldaprevir plus peginterferon and ribavirin in hepatitis C virus genotype 1‐infected patients who failed placebo plus peginterferon and ribavirin. Issue 3 (17th November 2015)

Authors:
Foster, G. R.; Ferenci, P.; Asselah, T.; Mantry, P.; Dufour, J.‐F.; Bourlière, M.; Forton, D.; Maevskaya, M.; Wright, D.; Yoshida, E. M.; García‐Samaniego, J.; Oliveira, C.; Wright, M.; Warner, N.; Sha, N.; Quinson, A.‐M.; Stern, J. O.
Journal:
Journal of viral hepatitis
Issue:
Volume 23:Issue 3(2016)
Page Start:
227
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Prevention of allograft HCV recurrence with peri‐transplant human monoclonal antibody MBL‐HCV1 combined with a single oral direct‐acting antiviral: A proof‐of‐concept study. Issue 3 (7th November 2016)

Authors:
Smith, H. L.; Chung, R. T.; Mantry, P.; Chapman, W.; Curry, M. P.; Schiano, T. D.; Boucher, E.; Cheslock, P.; Wang, Y.; Molrine, D. C.
Journal:
Journal of viral hepatitis
Issue:
Volume 24:Issue 3(2017)
Page Start:
197
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search